FDA Approved: LOTEPREDNOL ETABONATE — Original Application (ARMAS PHARMACEUTICALS INC.)

View source ↗

Summary

FDA approved Loteprednol etabonate ophthalmic suspension from Armas Pharmaceuticals Inc. under an Original Application for use in ocular inflammatory conditions…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Conjunctivitis
• Ocular Inflammation
• Postoperative Ocular Inflammation

Drugs mentioned

• Loteprednol etabonate ophthalmic suspension (Loteprednol etabonate)

Snippet

ORIG AP for LOTEPREDNOL ETABONATE (LOTEPREDNOL ETABONATE)